DNA-based nanotechnology stimulates potent antitumor immune responses
Thursday, September 10, 2020 - 14:30
in Biology & Nature
Combining their expertise in protein engineering and synthetic DNA technology, scientists successfully delivered nanoparticle antitumor vaccines that stimulated robust CD8 T cell immunity and controlled melanoma growth in preclinical models.